Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.33 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.33 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.33 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.33 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.33 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11415997 | 0.78 | ALDH1A1 (0.38) | ALDH1A1CYP1A2TSHRGRIN2DGRIN3B | |
| SCHEMBL325008 | 0.77 | ALDH1A1 (0.41) | ALDH1A1CYP1A2TSHRGRIN2DGRIN3B | |
| SCHEMBL4618339 | 0.76 | ALDH1A1 (0.44) | ALDH1A1CYP1A2TSHRGRIN2DGRIN3B | |
| SCHEMBL4426785 | 0.76 | ALDH1A1 (0.46) | ALDH1A1TSHRGRIN2DGRIN3BGRIN1 | |
| SCHEMBL10972334 | 0.74 | ALDH1A1 (0.42) | ALDH1A1CYP1A2TSHRGRIN2DGRIN3B | |
| SCHEMBL30904 | 0.73 | CYP1A2 (0.41) | ALDH1A1CYP1A2TSHRGRIN2DGRIN3B | |
| Ammonia Solution, Strong SCHEMBL8733453 | 0.71 | CYP1A2 (0.40) | ALDH1A1CYP1A2TSHRGRIN2DGRIN3B | |
| Hydrochloric Acid SCHEMBL11788098 | 0.71 | CYP1A2 (0.40) | ALDH1A1CYP1A2TSHRGRIN2DGRIN3B | |
| SCHEMBL5979774 | 0.71 | ABCB11 (0.39) | ALDH1A1CYP1A2TSHRGRIN2DGRIN3B | |
| SCHEMBL1484098 | 0.71 | CYP1A2 (0.40) | ALDH1A1CYP1A2TSHRGRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140288074-A1 | FUNGICIDAL PYRAZOLES | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-09-25 | — | — | US | disclosed |
| WO-2013126283-A1 | FUNGICIDAL PYRAZOLES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-08-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140288074-A1 | FUNGICIDAL PYRAZOLES | CYP1A1, CYP1B1, NOX3 | ALDH1A1 419/4885CYP1A2 7/4885TSHR 2840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.